National Biodiversity Authority

The National Biodiversity Authority (NBA) is a statutory and autonomous body constituted in 2003 under Section 8 of the Biological Diversity Act, 2002, with its headquarters at Chennai. It was created to give effect to India's obligations under the Convention on Biological Diversity (CBD), 1992 — particularly the three CBD objectives of conservation of biodiversity, sustainable use of its components, and fair and equitable sharing of benefits arising from the use of genetic resources (the ABS principle later codified in the Nagoya Protocol, 2010, which India ratified in 2012). The Act establishes a three-tier institutional structure: the NBA at the national level, the State Biodiversity Boards (SBBs) at the state level, and the Biodiversity Management Committees (BMCs) at the local body level, each with distinct regulatory and documentation functions.

The NBA's core functions flow from Sections 3, 4, 6, 18 and 21 of the Act. It regulates access to biological resources and associated traditional knowledge by foreigners, non-resident Indians, and foreign corporations under Section 3, and grants approval for transferring research results or applying for intellectual property rights (patents) based on Indian biological resources under Sections 4 and 6. It advises the Central Government on conservation, notification of Biodiversity Heritage Sites under Section 37, and on threatened species. A central mandate is access and benefit-sharing (ABS): the NBA imposes benefit-sharing conditions and can take measures to oppose the grant of IPRs in foreign countries on Indian biological resources or traditional knowledge — a power famously invoked in the turmeric, neem, and Basmati biopiracy episodes that motivated the legislation. The Authority is chaired by a full-time Chairperson with ex-officio and expert members drawn from relevant ministries.

A landmark application was the Divya Pharmacy v. Union of India (2018) judgment of the Uttarakhand High Court, which upheld the power of state authorities to levy fair and equitable benefit-sharing (FEBS) charges even on Indian companies, affirming the sovereign right over biological resources. The legislative framework was significantly amended by the Biological Diversity (Amendment) Act, 2023, which decriminalised offences (replacing imprisonment with monetary penalties adjudicated by an authority), eased compliance for AYUSH practitioners and registered traditional medicine cultivators, and exempted codified traditional knowledge and cultivated medicinal plants from certain ABS requirements — changes that drew criticism from conservationists for diluting biopiracy safeguards. As of 2026, the NBA continues to administer the People's Biodiversity Registers (PBRs) prepared by BMCs, which document local biological resources and knowledge.

For UPSC, the NBA appears in the General Studies Paper III (Environment and Ecology, conservation, biodiversity) and occasionally Paper II (statutory bodies). Prelims questions typically test the parent Act (Biological Diversity Act, 2002, not a constitutional body), the three-tier structure, the headquarters at Chennai, and the linkage to the CBD and Nagoya Protocol. Mains questions probe the adequacy of India's ABS regime, the implications of the 2023 amendment, and the role of BMCs and PBRs in decentralised biodiversity governance. Candidates should distinguish the NBA from the Wildlife Crime Control Bureau and the National Green Tribunal.